# A5 ADVERSARY / COMPLETENESS AUDIT — LAXMI INDIA FINANCE (LAXMIINDIA, BSE 544465) — Q1 FY27

**Agent:** A5 ADVERSARY | **Model:** claude-opus-4-8 | Fresh context: audits the A4 merged review against the A1 extracts and A2 ledgers only. Re-derives independently; does not defer to A4's or A3's cites.

**Verdict up front: INCOMPLETE.** One hard arithmetic FAIL (Step 3 QoQ table, derived Q2+Q3 FY26 PPOP). Loop back to **A4**. Everything else — the deliverable brief, coverage, the EPS conflict, the standalone-only PAT treatment, Role 5 N.A., Decision Status UNSET, the adversarial symmetry — passes. Details below.

---

## AUDIT 0 — DELIVERABLE-COMPLETENESS (hard gate, run first)

The A4 review carries a PLAIN-LANGUAGE BRIEF (review lines 346-366) with all four labelled parts present and non-empty:

| Part | Heading present | Location | Content check | Status |
|---|---|---|---|---|
| 1. Summary narrative | yes | L348-354 | 3 paragraphs, ~15 lines; real numbers (NII +39%, PAT +70%, GNPA 1.28→2.08, D/E 3.10 vs 4.13, EPS 3.07/3.17 flag, Decision Status unset) | PRESENT |
| 2. Sector intelligence | yes | L356-358 | NBFC-ML band, semi-urban credit demand, 37% first-time borrowers, ARC-masked prior year, Acuité "A" upgrade; flags no-peer-work caveat | PRESENT |
| 3. Business-model intelligence | yes | L360-362 | 184 branches / Rajasthan 92, spread mechanics (10.66% borrow / 21.89% yield / 11.01% spread), ~28% net-worth funded, unsecured PL/wholesale drift, co-lending/assignment nil levers | PRESENT |
| 4. Competition intelligence | yes | L364-366 | Where-it-wins / where-it-is-weaker symmetric read, 47-plus lenders, sub-scale AUM, ROE trailing peers, unsecured push risk; unaudited-claims caveat | PRESENT |

Gate 0: **PASS.** No placeholder text; each part carries substantive, number-anchored content.

---

## AUDIT 1 — COVERAGE (fresh enumeration diffed against A2 ledgers)

Independent recount vs A2 ledger counts:

| Category | A2 count | My fresh count | Method | Orphan rows | Status |
|---|---|---|---|---|---|
| Notes to results | 16 | 16 | extract notes 1-12 + 8.1-8.4 (res L744-866); all in A4 Step 0D table | none | PASS |
| Board agenda items | 2 | 2 | res L92 (results approval), L130 (AGM notice); both in A4 preamble + monitorables | none | PASS |
| Board sub-enclosures | 4 | 4 | res L100/107/109/119; dispositioned in preamble | none | PASS |
| Limited-Review paras | 5 | 5 | res L335/345/357/404/424 (+433 closing); A4 Step 0D uses paras 4/5 for unmodified opinion | none | PASS |
| Asset-cover-cert paras | 13 | 13 | res L1670-1921; para 7 "audit" mislabel → A4 T5/Q11 (A3-07) | none | PASS |
| P&L line items | 29 | 29 | res L521-698; all mapped into A4 Step 1L / bridge | none | PASS |
| Reg 52(4) disclosures | 23 | 23 | res L1017-1131 (18 items + Note + 4 sector); EPS 3.17 (L1066), GNPA 2.08/NNPA 0.94/CRAR 25.32 all in A4 | none | PASS |
| Annexure-I fields | 20 | 20 | res L1304-1452 (all NA/nil, ZERO_STANDING) — A4 covers via Q9/A3-01 (nil NCD-proceeds activity) | none | PASS |
| Annexure-A units | 12 | 12 | res L1992-2129; Debt Securities 55.05 Cr used by A4 | none | PASS |
| Appendix-1 line items | 17 | 17 | res L2349-2366 (OCR LOW_CONFIDENCE); A4 uses only Debt-Sec 55.05, caveated | none | PASS |
| Signature blocks | 9 | 9 | res L241-2164; "(Director)" NOT-FOUND name noted in ledger, not material to A4 findings | none | PASS |
| Presentation slides | 47 | **47** (grep `^\[page [0-9]+\]` = 47, independently re-run) | A4 preamble "47 slides, all reviewed" | none | PASS |
| Presentation footnotes | 5 | 5 | pres L178, L179, L357, L923, L1411 | none (see note) | PASS |

**Zero-value / zero-standing lines (special check — none silently dropped):**
- Notes 8.1-8.4 (nil assignment/securitisation/stressed-loan transfer, res L833-838): addressed — A4 Step 0D table rows + management Q9 (A3-01). PASS.
- Slide 13 "Sold to ARC" 0.00 current qtr vs FY26 (27.93) (pres L421): addressed — this is the spine of F1-a, Step 3 one-off caveat, Step 5, tripwire T2, Q3. PASS.
- Slide 13 "Write offs" Stage-1/2 = 0.00 (pres L423): addressed — Step 5 reconciles 0.68 (P&L) vs 1.01 (Stage-3 roll). PASS.
- Note 11 co-lending nil / self-contradictory (res L857): addressed — A4 Step 0D + Q8 (A3-09). PASS.
- Slide 36 dash-valued vertical cells (PL/wholesale nil in early FY, pres L1087): addressed — F16-e, T3, Q4. PASS.
- P&L Exceptional Items nil (res VI): addressed — Step 2 diagnostic 3 ("no exceptional items, VII=V"). PASS.

**Footnote-coverage note (not a FAIL):** the 5 deck footnotes are each traceable into A4's themes — net D/E 2.57x (pres L178) → leverage/F6-a; "annualized wherever required" (L179) → A4's annualised-ratio treatment; FY26 CRAR-26.91%-if-FDs (L357) → CRAR discussion; Credit Committee composition (L923) → credit-appraisal / ticket-size (T3); promoter 60.17% cumulative (L1411) → NEUTRAL-FACT, folded per A4 (F16-b/c neutral-fact fold). None is a forward-signal item requiring a management question, and none is silently dropped. No orphan.

**Coverage verdict: PASS.** Fresh counts match A2 on every category; no orphan ledger row; no zero-standing line dropped; nothing my pass found that the ledger lacks.

---

## AUDIT 2 — ARITHMETIC (recomputed from raw extract lines)

Anchor lines: results P&L res L521-698; Reg 52(4) res L1054-1129; presentation Slide 16 pres L505-529; Slides 7/9/10/11/12/13/17.

| Metric | A4 value | My recompute | Source line(s) | Status |
|---|---|---|---|---|
| Interest Income Q1FY27 (Cr) | 85.44 | 8,543.92 L ×0.01 = 85.44 | res L521 | PASS |
| Finance Costs Q1FY27 (Cr) | 38.38 | 3,837.72 L ×0.01 = 38.38 | res L552 | PASS |
| PBT Q1FY27 (Cr) | 21.90 | 2,190.95 L ×0.01 = 21.91 (pres shows 21.90) | res L594 / pres L525 | PASS (0.01 rounding, both cited) |
| Total Tax Q1FY27 (Cr) | 5.34 | 533.69 L ×0.01 = 5.34 | res L616 | PASS |
| Profit for period pre-OCI (Cr) | 16.57 | 1,657.26 L ×0.01 = 16.57 | res L628 | PASS |
| PAT incl OCI Q1FY27 (Cr) | 16.43 | Reg52(4) 1,643.08 L ×0.01 = 16.43 | res L1059; pres L529 | PASS |
| EPS Basic P&L (Rs) | 3.07 | 3.07 as printed | res L685 | PASS (conflict, see below) |
| EPS Diluted P&L (Rs) | 3.16 | 3.16 as printed | res L688 | PASS |
| EPS Basic Reg 52(4) (Rs) | 3.17 | 3.17 as printed | res L1066 | PASS |
| EPS Diluted Reg 52(4) | ND (NOT FOUND) | no value at line | res L1068 | PASS |
| NII YoY % | +38.97% | 47.06/33.86−1 = +38.98% (pres 38.97%) | pres L507 | PASS |
| PPOP YoY % | +76.82% | 25.60/14.48−1 = +76.80% (pres 76.82%) | pres L517 | PASS |
| Other Income YoY % | +184.29% | 8.48/2.98−1 = +184.6% (pres 184.29%) | pres L510 | PASS (pres-sourced 2-dp) |
| PBT YoY % | +71.59% | 21.90/12.76−1 = +71.6% (pres 71.59%) | pres L525 | PASS |
| PAT incl OCI YoY % | +70.17% | 16.43/9.65−1 = +70.3% (pres 70.17%) | pres L529 | PASS |
| Cost-to-Income Q1FY26 | 60.7% | 22.37/(33.86+2.98) = 60.72% | pres L516/507/510 | PASS |
| Cost-to-Income Q1FY27 | 53.9% | 29.94/(47.06+8.48) = 53.91% | pres L516/507/510 | PASS |
| Cost-to-Income Q4FY26 | 48.2% | 27.59/(52.11+5.10) = 48.23% | pres L516/507/510 | PASS |
| ETR Q1FY27 | 24.37% | 5.34/21.90 = 24.38% (pres 24.37%) | pres L527 | PASS |
| ETR step-up | +95bps | 24.37−23.42 = 0.95pp | pres L527 | PASS |
| AUM growth YoY | +27.91% | 1,721.74/1,346.05−1 = +27.91% | pres L143/146 | PASS |
| Own-book growth YoY | +31.74% | 1,626.90/1,234.89−1 = +31.74% | pres L152 | PASS |
| Net-worth growth YoY | +79.81% | 482.79/268.50−1 = +79.81% | pres L542 | PASS |
| Stage-3 Δ absolute | +1.46 | 33.49−32.03 = 1.46 | pres L425 (both tables) | PASS |
| ESOP paid-up Δ | +0.06 Cr | (2,619.65−2,613.39)L = 6.26 L = Rs 0.06 Cr; 1,25,203×5 = Rs 6.26 L | res L679/843 | PASS |
| CRAR Δ YoY | +504bps | 25.32−20.28 = 5.04pp | pres L349-355 | PASS |
| PAT bridge (all rungs) | +6.78 net | 13.20+5.50−7.57−1.98−2.35−0.02 → +6.78 | Step 4 vs pres L505-529 | PASS |
| Other-income strip PBT | ~16.40 / +28.5% | 21.90−5.50 = 16.40; 16.40/12.76−1 = +28.5% | Step 2/4 | PASS |
| **QoQ derived: Q2+Q3 FY26 NII** | 75.81 | 161.78−33.86−52.11 = 75.81 | pres L507 | PASS |
| **QoQ derived: Q2+Q3 FY26 PBT** | 26.21 | 66.05−12.76−27.08 = 26.21 | pres L525 | PASS |
| **QoQ derived: Q2+Q3 FY26 PAT** | 19.45 | 49.68−9.65−20.58 = 19.45 | pres L529 | PASS |
| **QoQ derived: Q2+Q3 FY26 PPOP** | **40.00** | **80.10−14.48−29.62 = 36.00** | pres L517 | **FAIL** |

### ARITHMETIC FAIL (1) — Step 3 QoQ table, Q2+Q3 FY26 (derived) PPOP

- **A4 value:** 40.00 (review line 153, column "PPOP (Rs Cr)").
- **Recomputed:** 80.10 − 14.48 − 29.62 = **36.00**.
- **Source lines:** presentation Slide 16, "Profit Before Impairment & Tax": FY26 = 80.10, Q1FY26 = 14.48, Q4FY26 = 29.62 (pres L517, independently re-read).
- **Discrepancy:** 4.00 Cr, well above rounding. The error is internal to A4: its own stated derivation method for that row is "FY26 minus Q1 minus Q4" (review L154 column), which yields 36.00, not 40.00. The three sibling cells in the same row (NII 75.81, PBT 26.21, PAT 19.45) were computed correctly by the same method; only PPOP is wrong. The companion note "avg ~37.9 NII/qtr" is right; the implied PPOP average (36.00/2 = 18.0) contradicts the printed 40.00.
- **Loop back to:** A4. Fix the derived PPOP cell to 36.00 and re-check any prose that leans on it (none downstream does — the H1-average and run-rate diagnostics all key off NII 75.81/37.9, which are unaffected).

No other arithmetic mismatch found. The scattered ±0.01-0.03pp gaps between A4's growth figures and my recompute are all attributable to the presentation's own 2-decimal rounding of the inputs A4 (correctly) cited; none exceeds rounding.

### EPS conflict — checked (as instructed)

Verified against raw lines, not A4's assertion: Basic EPS is printed **3.07** in the statutory P&L (res L685) and **3.17** in the Reg 52(4) table (res L1066), same quarter/company/document; P&L Diluted is **3.16** (res L688), which sits above its own Basic 3.07 — impossible with live dilutive ESOPs (Notes 9/10). Reg 52(4) Diluted is genuinely absent (res L1068, NOT FOUND). A4 reported all four values correctly, did not silently pick one, and routed the conflict to management Q1 and tripwire T5. Correct handling.

### Standalone-only PAT — checked (as instructed)

Filing scope is STANDALONE ONLY (LRR res L335; A2 grep `consolidat*` = zero body hits). A4 records S-vs-C PAT gap = ND for every period and explicitly labels it "a disclosure gap, not clean" (review L222, L333-342), routing to Q10 (A3-12). The PAT figures A4 uses (16.43 incl-OCI; 16.57 pre-OCI) both tie to raw lines (res L1059 / L628). No consolidated figure was invented. Correct.

---

## AUDIT 3 — ADVERSARIAL READ (three most-positive claims, strongest bear counter from the SAME extract)

| # | A4's positive claim | Strongest bear counter from the extract | Survives? | Already in A4? |
|---|---|---|---|---|
| 1 | "NII +39% YoY with genuine spread expansion, PPOP +77%... headline growth is real, not treasury-driven" (Step 2 diag 1/3) | Other Income spiked +184% to 8.48 Cr (15.3% of net income, up from 8.1%), source/recurrence undisclosed (pres L510); and NII/COB flattery is partly post-IPO de-leveraging, not durable operating gain — net worth +79.81%, D/E 2.87→3.10 vs FY26 4.13 (pres L542/L331-344); QoQ every line steps DOWN (NII −9.69%, PBT −19.11%) | Yes | **Yes** — Step 2 diag 5/6, Step 3, F6-a, Q5, Q… fee-mix. Already grafted; symmetric. |
| 2 | RoA 3.45%, rating upgraded to "A", asset base healthy (Step 1L / brief) | FY26 asset-quality optics leaned on a Rs 27.93 Cr ARC sale (incl 1.83 Stage-3), pres L421; with nil ARC this quarter GNPA rose 1.28→2.08%, NNPA 0.67→0.93%, credit cost 0.58→0.95%, provisions ~doubled; the FY26 "Without Up-Money Default" GNPA of 0.80% vs "With" 2.13% is a company-defined, undefined bifurcation that flatters the prior year (pres L380-388) | Yes | **Yes** — F1-a, F16-a, Step 3 one-off caveat, Step 5, T2, Q2/Q3. Already grafted. |
| 3 | "Merits promotion... under-levered post-IPO balance sheet gives real transition-alpha optionality," CRAR 25.32% (Step 8) | Under-leverage caps ROE at 13.86%, already at/below the 13.5-14.0% medium-term target (pres L580), so the "optionality" requires re-leveraging that itself reintroduces asset-quality strain; and the growth mix is drifting into unsecured Personal Loans (ticket up to Rs 200 lakh) and wholesale on-lending built from nil (pres L1050-1092), raising forward credit cost just as GNPA rises | Yes | **Yes** — F6-a, F16-e, T3/T7, Q4/Q5. Already grafted. |

**Adversarial verdict: PASS.** All three strongest bear counters are supported by the extract AND already incorporated into A4's review — the review is symmetric, not one-sided. No surviving bear counter needs to be added to A4. (This is the A5 completeness device only; the full Role 3 Devil's Advocate still runs separately.)

---

## PROTOCOL / SCOPE CHECKS

- **Role 5 correctly N.A.:** 0 concall turns in ledger; A4 marks Role 5 N.A. (review L3, L274-276), treats the deck as a Role 4 management-prepared input, and parks the Step 8.5 questions as the future Role 5 submission set. Correct.
- **Decision Status UNSET (new name):** verified — no Notion page, no companies/LAXMIINDIA.md, branch 8A-W, position framing barred, no valuation/fair value/entry zone produced (review L6, L27, L257-264). No buy/sell/hold language appears. Correct.
- **Forward-signal → management question mapping:** every A3 FORWARD-SIGNAL / AMBIGUOUS finding maps to a question — 17 findings → 17 questions (Q1-Q17), NEUTRAL-FACT items (A3-10/11, F6-b, F9-a, F14-a, F16-b/c) folded in. No forward-signal item left un-questioned; the FORWARD_TARGET (Slide 19) and ZERO_DEFAULT_CLAIM (Slide 20) both surface (Q5, Q15). Correct.
- **Cash conversion:** INDETERMINATE, capped below clean PROCEED with missing evidence named (half-yearly CFO at Q2, collection efficiency, restructured book) — consistent with house rule. Correct.

---

## VERDICT

**INCOMPLETE.** Loop back to **A4**.

**Exact gap:** Step 3 QoQ trajectory table (review line 153), "Q2+Q3 FY26 (derived)" PPOP cell reads **40.00**; the correct value under A4's own stated derivation ("FY26 minus Q1 minus Q4") is **80.10 − 14.48 − 29.62 = 36.00** (presentation Slide 16, pres L517). Discrepancy 4.00 Cr, above rounding, and internally inconsistent with the three correctly-derived sibling cells in the same row. Correct the cell to 36.00; no downstream prose depends on the wrong value, so this is a single-cell fix.

Everything else — deliverable brief (all four parts), coverage (all A2 counts re-derived and matched, zero orphan rows, no zero-standing line dropped), the EPS 3.07/3.17 conflict, the standalone-only PAT treatment, Role 5 N.A., Decision Status UNSET, forward-signal→question mapping, and bull-bear symmetry — passes. Re-run A5 after the A4 fix; expected to clear to COMPLETE.

```yaml
stage: A5-adversary
company: "LAXMIINDIA"
quarter: "Q1 FY27"
model: claude-opus-4-8
status: complete
verdict: INCOMPLETE
plain_language_brief:
  narrative: present
  sector: present
  business_model: present
  competition: present
coverage:
  orphan_rows: []
  missing_from_ledger: []
arithmetic_mismatches:
  - metric: "Step 3 QoQ table — Q2+Q3 FY26 (derived) PPOP"
    a4_value: "40.00"
    recomputed: "36.00"
    source_line: "presentation Slide 16, pres L517 (FY26 80.10 − Q1FY26 14.48 − Q4FY26 29.62)"
surviving_bear_counters: []
loop_back_to: "A4"
gap: "Step 3 QoQ table (review L153): derived Q2+Q3 FY26 PPOP shows 40.00; correct = 80.10 − 14.48 − 29.62 = 36.00 (pres L517). 4.00 Cr error, above rounding, inconsistent with A4's own stated 'FY26 minus Q1 minus Q4' method and with the row's correct NII/PBT/PAT cells."
```
